Scheduled Maintenance Notice

Please note that Researcher Profiles will be undergoing scheduled maintenance on Wednesday 7th Oct, from 8:00am to 9:00am. During this time, the Researcher Profiles system will be unavailable. We apologise for any inconvenience and appreciate your understanding.

Select Publications

Journal articles

Pham JP; Joshua AM; da Silva IP; Dummer R; Goldinger SM, 2023, 'Chemotherapy in Cutaneous Melanoma: Is There Still a Role?', Current Oncology Reports, 25, pp. 609 - 621, http://dx.doi.org/10.1007/s11912-023-01385-6

Pham JP; Boot M; Stefani M; Chapman S; Byrne A; Abdel-Shaheed C; Girgis L, 2023, 'Disseminated Mycobacterium chelonae infection complicating rheumatoid arthritis: A case report and review of the literature', International Journal of Rheumatic Diseases, 26, pp. 1167 - 1171, http://dx.doi.org/10.1111/1756-185X.14605

Pham JP; Yang A; Frew JW, 2023, 'Academic dermatology in Australia and New Zealand between 2017 and 2022: A cross-sectional bibliometric analysis', Australasian Journal of Dermatology, 64, pp. 213 - 220, http://dx.doi.org/10.1111/ajd.14025

Pham JP; Hillman RJ; Smith A, 2023, 'Re: ‘The impact of systemic psoriasis treatments on human papillomavirus activation and propagation’—What about anal malignancies?', Australasian Journal of Dermatology, 64, pp. e204 - e206, http://dx.doi.org/10.1111/ajd.14009

Pham JP; Sivasubramaniam V; Gallagher R; Forstner D; Wong M; Liu J, 2023, 'Safety of cemiplimab for advanced cutaneous squamous cell carcinoma in a patient with p-ANCA-associated vasculitis', Journal of the European Academy of Dermatology and Venereology, 37, pp. e363 - e365, http://dx.doi.org/10.1111/jdv.18649

Pham JP; Hurwitz J; Cosman R; Goldinger SM; Sim H-W; Dummer R; Joshua AM, 2023, '1127P Efficacy of immune checkpoint inhibitors (ICIs) in advanced mucosal melanoma (MM): A systematic review and meta-analysis', Annals of Oncology, 34, pp. s677, http://dx.doi.org/10.1016/j.annonc.2023.09.2261

Ahern K; Pham J; Sanderson R; De Farias MC; Walsh K, 2023, 'The nutritional impact of CD19‐targeted CAR‐T therapy versus BEAM chemotherapy for adult patients with lymphoma', Journal of Human Nutrition and Dietetics, 36, pp. 2099 - 2107, http://dx.doi.org/10.1111/jhn.13210

Pham JP; Star P; Smith A, 2022, 'Morbilliform eruption and systemic inflammatory response syndrome following mRNA COVID-19 vaccination in a patient receiving penicillamine', International Journal of Women S Dermatology, 8, http://dx.doi.org/10.1097/JW9.0000000000000058

Pham JP; Allen N; Smith A, 2022, 'Efficacy of ustekinumab and guselkumab in treatment refractory pityriasis rubra pilaris: A case series', Australasian Journal of Dermatology, 63, pp. 522 - 524, http://dx.doi.org/10.1111/ajd.13925

Pham JP; Star P; Phan K; Loh Y; Joshua AM; Smith A, 2022, 'BRAF inhibition and the spectrum of granulomatous reactions', Journal of the American Academy of Dermatology, 87, pp. 605 - 613, http://dx.doi.org/10.1016/j.jaad.2021.10.030

Pham JP; Beale G; Gorji M; Thompson B; Al-Soufi S; Stone E, 2022, 'Severe disseminated primary varicella in a patient on long term inhaled corticosteroids', Respirology Case Reports, 10, http://dx.doi.org/10.1002/rcr2.1010

Pham JP; Star P; Ardolino L; Smith A; Joshua AM, 2022, 'A review of the cutaneous toxicities of tebentafusp—Featuring two cases involving superficial bullous reactions', Australasian Journal of Dermatology, 63, pp. e279 - e282, http://dx.doi.org/10.1111/ajd.13866

Pham JP; Aivazian K; Smith A, 2022, 'Acute generalised exanthematous pustulosis and cutaneous vasculitis: Not always just pustules?', Australasian Journal of Dermatology, 63, pp. 136 - 139, http://dx.doi.org/10.1111/ajd.13776

Pham JP; Star P; Wong S; Damian DL; Saw RPM; Whitfeld MJ; Menzies AM; Joshua AM; Smith A, 2021, 'Cutaneous sarcoidosis due to immune-checkpoint inhibition and exacerbated by a novel BRAF dimerization inhibitor', Skin Health and Disease, 1, http://dx.doi.org/10.1002/ski2.71

Raiker R; Pakhchanian H; Pham J; Phan K, 2021, 'Coronavirus disease 2019 complications in patients with hidradenitis suppurativa: A multicenter analysis', Journal of Dermatology, 48, pp. 1619 - 1621, http://dx.doi.org/10.1111/1346-8138.16073

Williamson AE; Ylioja PM; Robertson MN; Avery V; Baell JB; Batchu H; Batra S; Burrows JN; Bhattacharyya S; Calderon F; Charman SA; Clark J; Crespo B; Dean M; Debbert SL; Delves M; Dennis ASM; Deroose F; Duffy S; Fletcher S; Giaever G; Hallyburton I; Gamo FJ; Gebbia M; Guy RK; Hungerford Z; Kirk K; Lafuente-Monasterio MJ; Lee A; Meister S; Nislow C; Overington JP; Papadatos G; Patiny L; Pham J; Ralph SA; Ruecker A; Ryan E; Southan C; Srivastava K; Swain C; Tarnowski MJ; Thomson P; Turner P; Wallace IM; Wells TNC; White K; White L; Willis P; Winzeler EA; Wittlin S; Todd MH; Antonova-Koch Y, 2016, 'Open source drug discovery: Highly potent antimalarial compounds derived from the tres cantos arylpyrroles', ACS Central Science, 2, pp. 687 - 701, http://dx.doi.org/10.1021/acscentsci.6b00086

Pham J; Wasyluk D; Small W, 2010, 'NOX Reduction Strategy', POWER ENGINEERING, 114, pp. 46 - +


Back to profile page